(KYPROLIS is registered trademarks of Onyx Pharmaceutical)
What is KYPROLIS:
KYPROLIS is a medicine that contains the active substance Carfilzomib and is available as a 60mg vial.
Kyprolis – Carfilzomib 60 mg is supplied for Tenders, Emergency imports, Orphan drug, Reference listed drugs, Comparator Drug, Name patient medicine and Innovator samples etc.
In how many countries KYPROLIS is approved for marketing?
KYPROLIS is available/approved in USA and Europe. We can help you to access it in India.
What is KYPROLIS used for?
KYPROLIS is indicated for the treatment of patients with multiple myeloma who have received at least two prior therapies including bortezomib and an immunomodulatory agent and have demonstrated disease progression on or within 60 days of completion of the last therapy is indicated for the treatment of patients with chronic lymphocytic leukemia (CLL) with 17p deletion.
How can I get KYPROLIS in India?
KYPROLIS is a prescription only drug and is not approved for marketing in India.
The Indian Pharma (IP) is a consulting pharmaceutical company which assists Patients in accessing medicines in India. The Indian Pharma facilitates such access only against valid prescriptions in conformity with all local laws and regulations.
Patients/ Clinicians / Researchers can contact IP at +91-120-4080562 or write to at – email@example.com
We facilitate by-
- Helping in documentation to import the medicine for personal use
- Finding Genuine and reliable source in USA, Europe and Japan
- Ensuring 100% transparency.
KYPROLIS can be shipped to Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Jaipur, Lucknow, Cochin and Pune and other cities in India.
The Indian Pharma can facilitate the supply of KYPROLIS (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement.
The Indian Pharma does not manufacture, supply, re-sell or retail any drugs or medicines. All trademarks and other intellectual property in relation to drugs and medicines supplied to you by suppliers are owned by their respective manufacturers or licensees.